|
ADSL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.600600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.302800E-01 |
| Normal-vs-Stage2 |
3.879800E-01 |
| Normal-vs-Stage3 |
3.531400E-01 |
| Normal-vs-Stage4 |
3.016600E-01 |
| Stage1-vs-Stage2 |
3.723800E-01 |
| Stage1-vs-Stage3 |
3.888400E-01 |
| Stage1-vs-Stage4 |
2.946600E-01 |
| Stage2-vs-Stage3 |
7.957800E-01 |
| Stage2-vs-Stage4 |
9.267600E-01 |
| Stage3-vs-Stage4 |
6.983000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.329000E-01 |
| Normal-vs-AfricanAmerican |
3.195800E-01 |
| Normal-vs-Asian |
9.211200E-01 |
| Caucasian-vs-AfricanAmerican |
3.469400E-01 |
| Caucasian-vs-Asian |
7.588000E-01 |
| AfricanAmerican-vs-Asian |
3.621200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.508300E-02 |
| Normal-vs-Female |
8.888800E-01 |
| Male-vs-Female |
7.834000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.682600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.009800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.289000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.533400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.463400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.677000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.855600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.899200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.885700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.782600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.692780E-01 |
| Classical-VS-Follicular |
1.376250E-02 |
| Classical-VS-Other |
7.699600E-02 |
| Classical-VS-Normal |
9.170600E-01 |
| Tall-VS-Follicular |
2.084100E-03 |
| Tall-VS-Other |
1.154210E-01 |
| Tall-VS-Normal |
1.129790E-01 |
| Follicular-VS-Other |
6.760800E-01 |
| Follicular-VS-Normal |
2.200200E-02 |
| Other-VS-Normal |
2.408400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.092200E-01 |
| Normal-vs-N1 |
1.756000E-01 |
| N0-vs-N1 |
4.930800E-01 |
|
|
